U
CLB icon

UBS’s Core Laboratories CLB Stock Holding History

UBS’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$15K Sell
100
-100
-50% -$15.4K ﹤0.01% 8344
2014
Q2 		$33K Buy
200
+100
+100% +$17.8K ﹤0.01% 7413
2014
Q1 		$20K Sell
100
-3,800
-97% -$717K ﹤0.01% 8064
2013
Q4 		$745K Buy
3,900
+400
+11% +$74.4K ﹤0.01% 3875
2013
Q3 		$592K Buy
3,500
+2,700
+338% +$419K ﹤0.01% 3952
2013
Q2 		$121K Buy
+800
New +$113K ﹤0.01% 5679

Other funds holding CLB

Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
VAM
Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
WI
WHV Investments San Francisco, California $187M AUM 14.29% 1-Year Est. Return

UBS's CLB Position: Q3 2014 in Review

UBS increased its Core Laboratories (CLB) stake by 43% in Q3 2014, buying an estimated $3.6M and bringing the position to 78,026 shares worth $11.4M. The position accounts for 0.01% of the portfolio, ranked #1347.

UBS first reported a position in CLB in Q2 2013 and has held it in 6 quarters since. 344 funds tracked by Wall St. Rank hold CLB as of Q3 2014.

  • UBS held 78,026 shares of Core Laboratories worth $11.4M as of Q3 2014.
  • UBS bought 23,312 Core Laboratories shares in Q3 2014, an estimated $3.6M.
  • Core Laboratories made up 0.01% of UBS's portfolio in Q3 2014, its #1347 holding.
  • UBS first reported a position in Core Laboratories in Q2 2013 and has held it in 6 quarters since.
  • 344 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.